article

Drug Target Review – Issue 4 2021

This issue includes articles that discuss the development of long-term 3D tissue cultures from human biopsy samples, the application of flow cytometry in drug discovery and automation for upstream processing in a biologics manufacturing environment. Also included are features on informatics, proteomics and CRISPR. 

In this issue:

  • PROTEOMICS
    Analysing proteomics data to translate in vivo studies as early as possible
    Dr Antal Szalay, Ultimate Medicine
  • UPSTREAM BIOPROCESSING
    Ensuring the safety and efficacy of biologics products
    Dr Shishir Chundawat and Aron Gyorgypal, Rutgers University
  • CRISPR
    CRISPR screens and novel drug targets
    Dr Jeffrey Rathmell and Ayaka Sugiura, Vanderbilt University
  • FLOW CYTOMETRY
    T-cell immunotherapies and flow cytometry
    Dr Alasdair Gunn and Natalie Bath, Adaptimmune
  • INFORMATICS
    Transformational machine learning approach could accelerate drug design
    Professor Ross King, University of Cambridge

 

Send this to a friend